Advertisement
Screener

CHINA BCT PHARMACY GROUP, INC. Increase (Decrease) in Other Receivables

CHINA BCT PHARMACY GROUP, INC. Increase (Decrease) in Other Receivables

CHINA BCT PHARMACY GROUP, INC. reported Increase (Decrease) in Other Receivables of $8.48 million for the 3-month period ending 2013-03-31, per its 10-Q filed 2013-05-20.

Discontinued › Cash Flow › Operating Activities

us-gaap:IncreaseDecreaseInOtherReceivables · last filed 2013-05-20

  • CHINA BCT PHARMACY GROUP, INC. increase (decrease) in other receivables for the quarter ending 2013-03-31 was $8.48M, a 180.86% increase year-over-year.
  • CHINA BCT PHARMACY GROUP, INC. increase (decrease) in other receivables for the quarter ending 2012-12-31 was -$4.14M, a 980.09% decline year-over-year.
  • CHINA BCT PHARMACY GROUP, INC. increase (decrease) in other receivables for the quarter ending 2012-09-30 was $3.81M, a 672.35% increase year-over-year.
  • CHINA BCT PHARMACY GROUP, INC. increase (decrease) in other receivables for the quarter ending 2012-06-30 was -$761.15K, a 499.99% decline year-over-year.
  • CHINA BCT PHARMACY GROUP, INC. increase (decrease) in other receivables for fiscal 2012 was $1.94M, a 21.07% increase from fiscal 2011.
  • CHINA BCT PHARMACY GROUP, INC. increase (decrease) in other receivables for fiscal 2011 was $1.60M, a 125.48% increase from fiscal 2010.
  • CHINA BCT PHARMACY GROUP, INC. increase (decrease) in other receivables for fiscal 2010 was $708.88K.
Period endIncrease (Decrease) in Other Receivables 3 monthIncrease (Decrease) in Other Receivables 6 monthIncrease (Decrease) in Other Receivables 9 monthIncrease (Decrease) in Other Receivables 12 month
2013-03-31$8.48M
10-Q · filed 2013-05-20
$4.35M
derived: sum of 2 quarters · filed 2013-05-20
$8.16M
derived: sum of 3 quarters · filed 2013-05-20
$7.40M
derived: sum of 4 quarters · filed 2013-05-20
2012-12-31-$4.14M
derived: 10-K 12 month − 10-Q 9 month · filed 2013-04-15
-$323.50K
derived: sum of 2 quarters · filed 2013-04-15
-$1.08M
derived: sum of 3 quarters · filed 2013-04-15
$1.94M
10-K · filed 2013-04-15
2012-09-30$3.81M
derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-15
$3.05M
derived: sum of 2 quarters · filed 2012-11-15
$6.07M
10-Q · filed 2012-11-15
$6.54M
derived: sum of 4 quarters · filed 2013-05-20
2012-06-30-$761.15K
derived: 10-Q 6 month − 10-Q 3 month · filed 2012-08-17
$2.26M
10-Q · filed 2012-08-17
$2.73M
derived: sum of 3 quarters · filed 2013-05-20
$3.22M
derived: sum of 4 quarters · filed 2013-05-20
2012-03-31$3.02M
10-Q · filed 2013-05-20
$3.49M
derived: sum of 2 quarters · filed 2013-05-20
$3.98M
derived: sum of 3 quarters · filed 2013-05-20
$4.17M
derived: sum of 4 quarters · filed 2013-05-20
2011-12-31$469.88K
derived: 10-K 12 month − 10-Q 9 month · filed 2013-04-15
$963.41K
derived: sum of 2 quarters · filed 2013-04-15
$1.15M
derived: sum of 3 quarters · filed 2013-04-15
$1.60M
10-K · filed 2013-04-15
2011-09-30$493.53K
derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-15
$683.82K
derived: sum of 2 quarters · filed 2012-11-15
$1.13M
10-Q · filed 2012-11-15
$802.20K
derived: sum of 4 quarters · filed 2012-11-15
2011-06-30$190.29K
derived: 10-Q 6 month − 10-Q 3 month · filed 2012-08-17
$634.99K
10-Q · filed 2012-08-17
$308.67K
derived: sum of 3 quarters · filed 2012-08-17
$5.49K
derived: sum of 4 quarters · filed 2012-08-17
2011-03-31$444.69K
10-Q · filed 2012-05-21
$118.38K
derived: sum of 2 quarters · filed 2012-06-12
-$184.80K
derived: sum of 3 quarters · filed 2012-06-12
2010-12-31-$326.31K
derived: 10-K/A 12 month − 10-Q 9 month · filed 2012-06-12
-$629.49K
derived: sum of 2 quarters · filed 2012-06-12
$708.88K
10-K/A · filed 2012-06-12
2010-09-30-$303.18K
derived: 10-Q 9 month − 10-Q 6 month · filed 2011-11-14
$1.04M
10-Q · filed 2011-11-14
2010-06-30$1.34M
10-Q · filed 2011-08-15